Correlation Between Armada Hflr and Context Therapeutics
Can any of the company-specific risk be diversified away by investing in both Armada Hflr and Context Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armada Hflr and Context Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Armada Hflr Pr and Context Therapeutics, you can compare the effects of market volatilities on Armada Hflr and Context Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armada Hflr with a short position of Context Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armada Hflr and Context Therapeutics.
Diversification Opportunities for Armada Hflr and Context Therapeutics
0.92 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Armada and Context is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Armada Hflr Pr and Context Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Context Therapeutics and Armada Hflr is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armada Hflr Pr are associated (or correlated) with Context Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Context Therapeutics has no effect on the direction of Armada Hflr i.e., Armada Hflr and Context Therapeutics go up and down completely randomly.
Pair Corralation between Armada Hflr and Context Therapeutics
Considering the 90-day investment horizon Armada Hflr Pr is expected to under-perform the Context Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Armada Hflr Pr is 3.81 times less risky than Context Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Context Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 68.00 in Context Therapeutics on December 5, 2024 and sell it today you would earn a total of 15.90 from holding Context Therapeutics or generate 23.38% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Armada Hflr Pr vs. Context Therapeutics
Performance |
Timeline |
Armada Hflr Pr |
Context Therapeutics |
Armada Hflr and Context Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Armada Hflr and Context Therapeutics
The main advantage of trading using opposite Armada Hflr and Context Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armada Hflr position performs unexpectedly, Context Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Context Therapeutics will offset losses from the drop in Context Therapeutics' long position.Armada Hflr vs. Modiv Inc | Armada Hflr vs. Precinct Properties New | Armada Hflr vs. Global Net Lease | Armada Hflr vs. NexPoint Diversified Real |
Context Therapeutics vs. Terns Pharmaceuticals | Context Therapeutics vs. Amylyx Pharmaceuticals | Context Therapeutics vs. Acumen Pharmaceuticals | Context Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |